Literature DB >> 8719368

The prognostic value of p53 in superficially infiltrating transitional cell carcinoma.

V Vatne1, H Maartmann-Moe, J Hoestmark.   

Abstract

Approximately 1/3 of T1 bladder cancers treated by endoscopic resection alone will progress. Prognostic factors are needed to help selecting appropriate treatment for these tumors. The purpose of the present investigation was to study the relation between p53 nuclear overexpression and disease progression. Tumors from 59 patients were studied by means of immunohistochemical nuclear staining. Forty tumors showed p53 nuclear overexpression while 19 tumors scored negative for mutations. We could not demonstrate any correlation between mutations of the p53 protein and tumor grading. p53 nuclear overexpression was not related to disease progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719368     DOI: 10.3109/00365599509180032

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  4 in total

1.  Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy.

Authors:  Lujia Wang; Minwei Zhou; Chenchen Feng; Peng Gao; Guanxiong Ding; Zhongwen Zhou; Haowen Jiang; Zhong Wu; Qiang Ding
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 2.  Molecular pathology of non-invasive urothelial carcinomas (part I).

Authors:  Burkhard Helpap; Bernd J Schmitz-Dräger; Peter W Hamilton; Giovanni Muzzonigro; Andrea B Galosi; Karl H Kurth; David Lubaroff; David J Waters; Michael J Droller
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

3.  Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer.

Authors:  Sven Gunia; Matthias May; Katharina Scholmann; Stephan Störkel; Bernd Hoschke; Stefan Koch; Manfred Dietel; Glen Kristiansen
Journal:  Virchows Arch       Date:  2008-07-22       Impact factor: 4.064

4.  p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis.

Authors:  Jun Du; Shu-hua Wang; Qing Yang; Qian-qian Chen; Xin Yao
Journal:  World J Surg Oncol       Date:  2016-04-30       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.